These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20088835)

  • 21. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
    Hilton DA
    J Pathol; 2006 Jan; 208(2):134-41. PubMed ID: 16362983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
    Brown P; Cervenáková L; Diringer H
    J Lab Clin Med; 2001 Jan; 137(1):5-13. PubMed ID: 11150018
    [No Abstract]   [Full Text] [Related]  

  • 24. Should deceased donors be tested for vCJD?
    Warwick RM; Eglin R
    Cell Tissue Bank; 2005; 6(4):263-70. PubMed ID: 16308765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice.
    Yakovleva O; Janiak A; McKenzie C; McShane L; Brown P; Cervenakova L
    Transfusion; 2004 Dec; 44(12):1700-5. PubMed ID: 15584983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P; Wessberg S; Tuomi K; Laitinen H
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease.
    Cervenakova L; Brown P; Soukharev S; Yakovleva O; Diringer H; Saenko EL; Drohan WN
    Electrophoresis; 2003 Mar; 24(5):853-9. PubMed ID: 12627447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UK approach to assessing assays and filters designed to reduce the risk of transfusion-transmitted vCJD.
    Thomas S; Turner ML; Williamson LM
    Transfus Clin Biol; 2013 Sep; 20(4):405-11. PubMed ID: 23928183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples.
    Malm K; von Sydow M; Andersson S
    Transfus Med; 2009 Apr; 19(2):78-88. PubMed ID: 19320855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans.
    Race R; Raines A; Raymond GJ; Caughey B; Chesebro B
    J Virol; 2001 Nov; 75(21):10106-12. PubMed ID: 11581378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion protein detection in serum using micromechanical resonator arrays.
    Varshney M; Waggoner PS; Montagna RA; Craighead HG
    Talanta; 2009 Dec; 80(2):593-9. PubMed ID: 19836525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
    Flan B; Arrabal S
    Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot to examine the logistical and feasibility issues in testing deceased tissue donors for vCJD using tonsil as the analyte.
    Warwick RM; Armitage WJ; Chandrasekar A; Mallinson G; Poniatowski S; Clarkson A
    Cell Tissue Bank; 2012 Mar; 13(1):53-61. PubMed ID: 21046259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSE clearance during plasma products separation process by Gradiflow(TM).
    Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H
    Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient propagation of variant Creutzfeldt-Jakob disease prion protein using the cell-protein misfolding cyclic amplification technique with samples containing plasma and heparin.
    Oshita M; Yokoyama T; Takei Y; Takeuchi A; Ironside JW; Kitamoto T; Morita M
    Transfusion; 2016 Jan; 56(1):223-30. PubMed ID: 26347231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW; Head MW
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay.
    Sowemimo-Coker SO; Demczyk CA; Andrade F; Baker CA
    Transfusion; 2010 May; 50(5):980-8. PubMed ID: 20003057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.